Search results
CANF Stock Soars 20% on Positive Mid-Stage Pancreatic Cancer Data
Can-Fite BioPharma CANF shares soared 20.4% on Wednesday after the company reported positive top-line results from a mid-stage study of its investigational candidate, namodenoson, in patients with
Hemispherx Biopharma
WKN: A2PLTT / Symbol: HEB / Name: Hemispherx Bio / Stock / Biotechnology & Medical Research / Micro Cap /
PDL BioPharma Inc.
WKN: A0H1J1 / Symbol: PDLI / Name: PDL BioPharma / Stock / Biotechnology & Medical Research / Small Cap /
Cti Biopharma Corp
WKN: A2DJWX / Symbol: CTIC / Name: CTi Biopharma / Stock / Biotechnology & Medical Research / Micro Cap /
Arca Biopharma
WKN: A2PGY6 / Symbol: ABIO / Name: ARCA / Stock / Pharmaceuticals / Micro Cap /
Theravance Biopharma
WKN: A1137V / Name: Theravance / Stock / Pharmaceuticals / Small Cap /
Benitec Biopharma Ltd ADR
WKN: A14XMT / Name: Benitec / Stock / Biotechnology & Medical Research / Micro Cap /
Cue Biopharma Inc
WKN: A2JAT5 / Symbol: CUE / Name: Cue Biopharma / Stock / Small Cap /
Sutro Biopharma Inc
WKN: A2N6SG / Symbol: STRO / Name: Sutro Biopharma / Stock / Biotechnology & Medical Research / Small Cap /
Benitec Biopharma Inc.
WKN: A2P06Q / Name: Benitec Biopharma / Stock / Biotechnology & Medical Research / Micro Cap /
Aytu Biopharma Inc.
WKN: A3D38R / Symbol: AYTU / Name: Aytu Biopharma / Stock / Micro Cap /


